Menu

• Ask a Health Expert about CAECITIS
• Post Your Side Effect related to CAECITIS
• CAECITIS and FDA Warnings
• CAECITIS in Patients Wiki
• Report CAECITIS in Drug Side Effect Survey

CAECITIS side effect

What is CAECITIS ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Velcade Side Effects Report #5664306-0
Physician from UNITED STATES reported VELCADE problem on Mar 01, 2008. Male patient, 76 years of age, weighting 155.4 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: caecitis, cough, dehydration, enteritis, haemoglobin decreased, hyperglycaemia, hypocalcaemia, hypokalaemia, hyponatraemia, . VELCADE dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, DEXAMETHASONE, NEULASTA. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5625438-6
CLOFARABINE problem was reported by a Physician from UNITED STATES on Jan 31, 2008. Male patient, child 10 years of age, weighting 110.2 lb, was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, chemical eye injury, collapse of lung, computerised tomogram abnormal, corneal abrasion, epistaxis, fatigue, febrile neutropenia, fungal infection, . CLOFARABINE dosage: unknown. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Doxorubicin Side Effects Report #5638414-4
Consumer or non-health professional from UNITED STATES reported DOXORUBICIN HYDROCHLORIDE problem on Feb 22, 2008. Male patient, weighting 83.78 lb, was treated with DOXORUBICIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: caecitis, cardiac failure congestive, dialysis, fluid overload, lactic acidosis, multi-organ failure, pulmonary hypertension, renal failure acute, septic shock, . DOXORUBICIN HYDROCHLORIDE dosage: 90 MG. During the same period patient was treated with METHOTREXATE, CISPLATIN, DEXTROSE, EPINEPHRINE, FLUCONAZOLE, HEPARIN, INFLUENZA VACCINE, LEUCOVORIN. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5646196-5
DECITABINE problem was reported by a Physician from THAILAND on Feb 22, 2008. Male patient, 77 years of age, weighting 147.7 lb, was diagnosed with myelodysplastic syndrome and was treated with DECITABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, cardiac arrest, metabolic acidosis, sepsis, . DECITABINE dosage: 25 MG, INTRAVENOUS. During the same period patient was treated with PREDNISOLONE, AMLODIPINE, FOLIC ACID, ATIVAN, SENNOKOT. Patient died on 02/12/2008.


Cytarabine Side Effects Report #5648016-1
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Feb 29, 2008. Male patient, weighting 194.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, intestinal perforation, . CYTARABINE dosage: 2912 MG. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5535722-2
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 04, 2007. Male patient, weighting 83.78 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: caecitis, cardiac disorder, cardiac failure congestive, dialysis, lactic acidosis, multi-organ failure, pulmonary hypertension, renal failure acute, septic shock, . CISPLATIN dosage: 145 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, METHOTREXATE, DEXTROSE, EPINEPHRINE, FLUCONAZOLE, HEPARIN, INFLUENZA VACCINE, LEUCOVORIN. Patient was hospitalized. Patient recovered.

Reductil Side Effects Report #5504453-7
Physician from FINLAND reported REDUCTIL problem on Oct 26, 2007. Female patient, 39 years of age, was diagnosed with weight control and was treated with REDUCTIL. After drug was administered, patient experienced the following problems/side effects: caecitis, dermographism, gout, pruritus, . REDUCTIL dosage: unknown. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5507072-1
DECITABINE problem was reported by a Physician from UNITED STATES on Oct 22, 2007. Female patient, 18 years of age, was diagnosed with acute myeloid leukaemia and was treated with DECITABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, cellulitis, disease progression, electrocardiogram t wave abnormal, febrile neutropenia, mouth injury, oral intake reduced, weight decreased, white blood cell count decreased, . DECITABINE dosage: 20 MG/M2, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with VORINOSTAT. Patient was hospitalized. Patient recovered.

Reductil Side Effects Report #5508335-6
Physician from FINLAND reported REDUCTIL problem on Oct 26, 2007. Female patient, 39 years of age, was diagnosed with weight control and was treated with REDUCTIL. After drug was administered, patient experienced the following problems/side effects: caecitis, dermographism, gout, pruritus, . REDUCTIL dosage: unknown. Patient was hospitalized. Patient recovered.


Cetuximab Side Effects Report #5520597-8
CETUXIMAB problem was reported by a Health Professional from GERMANY on Nov 09, 2007. Female patient, 55 years of age, was diagnosed with colorectal cancer and was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: caecitis, . CETUXIMAB dosage: unknown. During the same period patient was treated with FLUOROURACIL, FOLINIC ACID, OXALIPLATIN. Patient recovered.

Cisplatin Side Effects Report #5523233-X
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Nov 16, 2007. Male patient, weighting 83.78 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: caecitis, cardiac disorder, cardiac failure congestive, dialysis, fluid overload, lactic acidosis, multi-organ failure, pulmonary hypertension, renal failure acute, . CISPLATIN dosage: 145 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, METHOTREXATE, DEXTROSE, EPINEPHRINE, FLUCONAZOLE, HEPARIN, INFLUENZA VACCINE, LEUCOVORIN. Patient was hospitalized. Patient recovered.

Topotecan Side Effects Report #5472905-4
TOPOTECAN problem was reported by a Physician from UNITED STATES on Sept 19, 2007. Male patient, weighting 149.9 lb, was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: caecitis, febrile neutropenia, pain, . TOPOTECAN dosage: 1.5MGM2 CYCLIC. During the same period patient was treated with PACLITAXEL, ETOPOSIDE, NEUPOGEN, ALBUTEROL, IMODIUM, SALMETEROL. Patient was hospitalized. Patient died on 12/14/2002.

Docetaxel Side Effects Report #5479505-0
Health Professional from UNITED STATES reported DOCETAXEL problem on Sept 27, 2007. Female patient, 59 years of age, weighting 199.3 lb, was diagnosed with breast cancer and was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: caecitis, cholelithiasis, colitis, dehydration, diarrhoea, febrile neutropenia, hypokalaemia, septic shock, . DOCETAXEL dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, LEXAPRO, CITRICAL, ASCORBIC ACID, VITAMIN B. Patient was hospitalized. Patient recovered.

Docetaxel Side Effects Report #5482304-7
DOCETAXEL problem was reported by a Health Professional from UNITED STATES on Sept 27, 2007. Female patient, 59 years of age, weighting 199.3 lb, was treated with DOCETAXEL. After drug was administered, patient experienced the following problems/side effects: caecitis, cholelithiasis, colitis, dehydration, diarrhoea, febrile neutropenia, hypokalaemia, septic shock, . DOCETAXEL dosage: unknown. During the same period patient was treated with BEVACIZUMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, LEXAPRO, CITRICAL, ASCORBIC ACID, VITAMIN B. Patient was hospitalized. Patient recovered.


Bevacizumab Side Effects Report #5483703-X
Health Professional from UNITED STATES reported BEVACIZUMAB problem on Oct 02, 2007. Female patient, 59 years of age, weighting 199.3 lb, was diagnosed with breast cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: caecitis, cholelithiasis, septic shock, . BEVACIZUMAB dosage: 15 MG/KG, UNK. During the same period patient was treated with DOCETAXEL, CYCLOPHOSPHAMIDE, DOXORUBICIN, LEXAPRO, CITRACAL, ASCORBIC ACID. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5484728-0
CLOFARABINE problem was reported by a Physician from UNITED STATES on Sept 26, 2007. Male patient, child 10 years of age, weighting 110.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, collapse of lung, epistaxis, fatigue, febrile neutropenia, haematocrit decreased, haemoglobin decreased, hypokalaemia, lower respiratory tract infection fungal, . CLOFARABINE dosage: 28 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5491226-7
Physician from UNITED STATES reported DECITABINE problem on Oct 04, 2007. Female patient, 18 years of age, was diagnosed with acute myeloid leukaemia and was treated with DECITABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, cellulitis, cheilitis, electrocardiogram t wave abnormal, febrile neutropenia, lip pain, lip swelling, mouth injury, oral intake reduced, . DECITABINE dosage: 20 MG/M2, IN 1 DAY, INTRAVENOUS; 20 MG/M2, IN 1 DAY, INTRAVENOUS. During the same period patient was treated with VORINOSTAT. Patient was hospitalized. Patient recovered.

Clofarabine Side Effects Report #5467562-7
CLOFARABINE problem was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, child 1 years of age, weighting 22.05 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, pneumatosis intestinalis, . CLOFARABINE dosage: 40 MG/M2 QD X 5 IV. During the same period patient was treated with CYTARABINE, LACTOBACILLUS, VORICONAZOLE, BACTRIM, ZANTAC, QUESTRAN. Patient recovered.

Cap Side Effects Report #5467567-6
Consumer or non-health professional from UNITED STATES reported CAP VORINOSTAT UNK problem on Sept 13, 2007. Female patient, 18 years of age, weighting 114.0 lb, was diagnosed with acute myeloid leukaemia and was treated with CAP VORINOSTAT UNK. After drug was administered, patient experienced the following problems/side effects: caecitis, cellulitis, cheilitis, febrile neutropenia, herpes simplex, oral intake reduced, weight decreased, . CAP VORINOSTAT UNK dosage: 400 MG/DAILY/PO; 400 MG/DAILY/PO. During the same period patient was treated with CAP VORINOSTAT UNK, INJ DECITABINE UNK, INJ DECITABINE UNK. Patient was hospitalized. Patient recovered.


Clofarabine Side Effects Report #5419373-6
CLOFARABINE problem was reported by a Physician from UNITED STATES on Aug 08, 2007. Male patient, child 2 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, . CLOFARABINE dosage: 40 MG/M2 IV. During the same period patient was treated with CYTARABINE. Patient recovered.

Vincristine Side Effects Report #5423833-1
Health Professional from KOREA, REPUBLIC OF reported VINCRISTINE SULPHATE problem on Aug 22, 2007. Male patient, child 9 years of age, was diagnosed with brain neoplasm, convulsion, caecitis and was treated with VINCRISTINE SULPHATE. After drug was administered, patient experienced the following problems/side effects: caecitis, colonic pseudo-obstruction, convulsion, pancytopenia, pseudomembranous colitis, . VINCRISTINE SULPHATE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CARBOPLATIN, VALPROIC ACID, PHENYTOIN, TOPIRAMATE, CLONAZEPAM, ANTIBIOTICS. Patient recovered.

Topotecan Side Effects Report #5427580-1
TOPOTECAN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 20, 2007. Female patient was treated with TOPOTECAN. After drug was administered, patient experienced the following problems/side effects: caecitis, febrile neutropenia, . TOPOTECAN dosage: 1.5MGM2 CYCLIC. During the same period patient was treated with PACLITAXEL, ETOPOSIDE, FILGRASTIM. Patient died.

Clofarabine Side Effects Report #5427846-5
Physician from UNITED STATES reported CLOFARABINE problem on Aug 10, 2007. Male patient, child 10 years of age, weighting 110.2 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, cough, epistaxis, fatigue, febrile neutropenia, herpes zoster, hypokalaemia, lower respiratory tract infection fungal, lung disorder, . CLOFARABINE dosage: 28 MG QD X 5 IV. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Vincristine Side Effects Report #5441581-9
VINCRISTINE problem was reported by a Physician from KOREA, REPUBLIC OF on Aug 13, 2007. Female patient, child 9 years of age, was diagnosed with medulloblastoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: caecitis, colonic pseudo-obstruction, convulsion, pancytopenia, pseudomembranous colitis, . VINCRISTINE dosage: unknown. During the same period patient was treated with ETOPOSIDE, CISPLATIN, CARBOPLATIN, CLONAZEPAM. Patient was hospitalized. Patient recovered.

Cytarabine Side Effects Report #5392035-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on July 18, 2007. Female patient, weighting 183.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, neutropenic colitis, sinus tachycardia, . CYTARABINE dosage: 31360 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Cytarabine Side Effects Report #5392035-X
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on July 18, 2007. Female patient, weighting 183.4 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: caecitis, neutropenic colitis, sinus tachycardia, . CYTARABINE dosage: 31360 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.

Gemtuzumab Side Effects Report #5767930-X
Physician from NETHERLANDS reported GEMTUZUMAB OZOGAMICIN problem on June 04, 2008. Male patient, weighting 169.8 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: caecitis, gastrointestinal haemorrhage, renal failure, respiratory failure, . GEMTUZUMAB OZOGAMICIN dosage: 5.7 MG-FREQUENCY NOT PROVIDED (CUMULATIVE DOSE GIVEN 29.3MG). During the same period patient was treated with CEFTAZIDIME, ETOPOSIDE, CYTARABINE, IDARUBICIN. Patient was hospitalized. Patient recovered.

Vesanoid Side Effects Report #5772169-8
VESANOID problem was reported by a Physician from UNITED STATES on June 05, 2008. Female patient was treated with VESANOID. After drug was administered, patient experienced the following problems/side effects: caecitis, large intestine perforation, . VESANOID dosage: unknown. Patient was hospitalized. Patient recovered.

Cyclophosphamide Side Effects Report #5783139-8
Consumer or non-health professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on June 19, 2008. Male patient, weighting 54.01 lb, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: caecitis, colitis, disease recurrence, stomatitis, . CYCLOPHOSPHAMIDE dosage: 2880 MG. During the same period patient was treated with CYTARABINE, DOXORUBICIN HYDROCHLORIDE, METHOTREXATE, METHYLPREDNISOLONE, RITUXIMAB, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5787742-0
CISPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 24, 2008. Female patient, weighting 72.75 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: caecitis, unresponsive to stimuli, . CISPLATIN dosage: 144 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE, METHOTREXATE. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5739312-8
Consumer or non-health professional from UNITED STATES reported CARBOPLATIN problem on May 12, 2008. Female patient, weighting 16.98 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: caecitis, febrile neutropenia, lower respiratory tract infection fungal, . CARBOPLATIN dosage: 205 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, MESNA, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Carboplatin Side Effects Report #5743656-3
CARBOPLATIN problem was reported by a Consumer or non-health professional from UNITED STATES on May 19, 2008. Female patient, weighting 16.98 lb, was treated with CARBOPLATIN. After drug was administered, patient experienced the following problems/side effects: caecitis, febrile neutropenia, pulmonary mycosis, . CARBOPLATIN dosage: 205 MG. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN HYDROCHLORIDE, ETOPOSIDE, MESNA, VINCRISTINE SULPHATE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5743684-8
Physician from FRANCE reported VELCADE problem on May 06, 2008. Male patient, 52 years of age, weighting 158.7 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: caecitis, dyspnoea, enterocolitis, febrile neutropenia, ileus paralytic, tachycardia, . VELCADE dosage: 2.90 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCINE, METHOTREXATE, CORTANCYL, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5664306-0
VELCADE problem was reported by a Physician from UNITED STATES on Mar 01, 2008. Male patient, 76 years of age, weighting 155.4 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: caecitis, cough, dehydration, enteritis, haemoglobin decreased, hyperglycaemia, hypocalcaemia, hypokalaemia, hyponatraemia, . VELCADE dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, DEXAMETHASONE, NEULASTA. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5703535-4
Physician from UNITED STATES reported REVLIMID problem on Apr 01, 2008. Male patient, 80 years of age, weighting 143.3 lb, was diagnosed with mantle cell lymphoma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: caecitis, dehydration, diarrhoea, renal failure acute, . REVLIMID dosage: 10 MG, QD, ORAL. During the same period patient was treated with RITUXIMAB, ALLOPURINOL, AZELASTINE, ZYRTEC, DOCUSATE, PROSCAR, FLUCONAZOLE, NYSTATIN. Patient was hospitalized. Patient recovered.

Vesanoid Side Effects Report #5704052-8
VESANOID problem was reported by a Physician from UNITED STATES on Apr 08, 2008. Female patient was treated with VESANOID. After drug was administered, patient experienced the following problems/side effects: caecitis, large intestine perforation, . VESANOID dosage: unknown. Patient was hospitalized. Patient recovered.

Cisplatin Side Effects Report #5712906-1
Consumer or non-health professional from UNITED STATES reported CISPLATIN problem on Apr 21, 2008. Female patient, weighting 72.75 lb, was treated with CISPLATIN. After drug was administered, patient experienced the following problems/side effects: caecitis, unresponsive to stimuli, . CISPLATIN dosage: 144 MG. During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5270414-9
VELCADE problem was reported by a Physician from FRANCE on Mar 02, 2007. Male patient, 52 years of age, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: caecitis, diarrhoea, dyspnoea, febrile bone marrow aplasia, ileus paralytic, nausea, tachycardia, vomiting, . VELCADE dosage: 2.90 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5281249-5
Physician from FRANCE reported VELCADE problem on Mar 13, 2007. Male patient, 52 years of age, weighting 158.7 lb, was diagnosed with t-cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: caecitis, diarrhoea, dyspnoea, enterocolitis, febrile bone marrow aplasia, febrile neutropenia, hyperthermia, ileus paralytic, nausea, . VELCADE dosage: 2.90 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE, GRANOCYTE. Patient was hospitalized. Patient recovered.

Decitabine Side Effects Report #5657879-5
DECITABINE problem was reported by a Physician from TURKEY on Feb 22, 2008. Female patient, 64 years of age, weighting 163.1 lb, was treated with DECITABINE. After drug was administered, patient experienced the following problems/side effects: activated partial thromboplastin time prolonged, caecitis, disease progression, febrile neutropenia, fibrin d dimer increased, haemorrhage intracranial, liver function test abnormal, platelet count decreased, prothrombin time prolonged, . DECITABINE dosage: 225 MG, INTRAVENOUS. During the same period patient was treated with PIPERACILLIN TAZOBACTAM, AMIKACIN, PRIMAXIN, NETILMICIN SULPHATE, DEFEROXAMINE. Patient was hospitalized and became disabled. Patient died on 03/22/2007.

Etoposide Side Effects Report #5663643-3
Consumer or non-health professional from SPAIN reported ETOPOSIDE problem on Feb 27, 2008. Male patient, 63 years of age, was treated with ETOPOSIDE. After drug was administered, patient experienced the following problems/side effects: aeromona infection, caecitis, hypotension, neutropenic colitis, respiratory failure, . ETOPOSIDE dosage: unknown. During the same period patient was treated with CISPLATIN, CYTARABINE, PREDNISONE, CARMUSTINE, MELTHALAN. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5688091-1
VELCADE problem was reported by a Physician from UNITED STATES on Mar 17, 2008. Male patient, 76 years of age, weighting 155.4 lb, was diagnosed with mantle cell lymphoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: anorexia, caecitis, cough, dehydration, haemoglobin decreased, hyperglycaemia, hypocalcaemia, hypokalaemia, hyponatraemia, . VELCADE dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, DEXAMETHASONE, NEULASTA, PREVACID, BACTRIM. Patient was hospitalized. Patient recovered.

Accutane Side Effects Report #5638891-9
Physician from UNITED STATES reported ACCUTANE problem on Feb 15, 2008. Male patient, 16 years of age, weighting 177.9 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: anxiety, caecitis, colitis, colitis ulcerative, depression, fear, fracture, oesophageal candidiasis, proctitis, . ACCUTANE dosage: unknown. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5590357-0
CLOLAR problem was reported by a Physician from UNITED STATES on Jan 03, 2008. Male patient, 24 years of age, weighting 151.7 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: arthritis infective, caecitis, enterobacter infection, enterocolitis infectious, fungal infection, hypotension, post procedural complication, pseudomonas infection, sepsis, . CLOLAR dosage: 40 MG/M2, QDX5, INTRAVENOUS. During the same period patient was treated with CYTARABINE, GENTAMYCIN, NEURONTIN, MORPHINE, FLAGYL, MYCOSTATIN, VORICONAZOLE, ZOFRAN. Patient was hospitalized. Patient died on 12/15/2007.

Cap Side Effects Report #5552555-1
Consumer or non-health professional from UNITED STATES reported CAP VORINOSTAT UNK problem on Nov 21, 2007. Female patient, 18 years of age, weighting 114.0 lb, was diagnosed with acute myeloid leukaemia and was treated with CAP VORINOSTAT UNK. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, caecitis, cellulitis, cheilitis, erythema, febrile neutropenia, herpes simplex, insomnia, lip swelling, . CAP VORINOSTAT UNK dosage: 400 MG/DAILY/PO. During the same period patient was treated with CAP VORINOSTAT UNK, DECITABINE UNK, DECITABINE UNK, DILAUDID, DURAGESIC, NORVASC, SENOKOT, ZOFRAN. Patient was hospitalized. Patient died on 10/25/2007.

Accutane Side Effects Report #5554090-3
ACCUTANE problem was reported by a Physician from UNITED STATES on Dec 05, 2007. Male patient, 16 years of age, weighting 177.9 lb, was diagnosed with acne and was treated with ACCUTANE. After drug was administered, patient experienced the following problems/side effects: anxiety, caecitis, colitis, colitis ulcerative, depression, fear, fracture, oesophageal candidiasis, proctitis, . ACCUTANE dosage: unknown. Patient was hospitalized. Patient recovered.

Clolar Side Effects Report #5570303-6
Consumer or non-health professional from UNITED STATES reported CLOLAR problem on Dec 19, 2007. Male patient, weighting 151.7 lb, was treated with CLOLAR. After drug was administered, patient experienced the following problems/side effects: blood lactic acid increased, caecitis, colitis, enterobacter infection, enterococcal infection, fungal infection, hypotension, pseudomonas infection, refusal of treatment by relative, . CLOLAR dosage: 73 MG. During the same period patient was treated with CYTARABINE. Patient was hospitalized. Patient recovered.

Cytarabine Side Effects Report #5507581-5
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 05, 2007. Male patient, weighting 75.40 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: bacteraemia, caecitis, enterococcal infection, escherichia infection, multi-organ failure, pancytopenia, septic shock, . CYTARABINE dosage: 1280 MG. During the same period patient was treated with MYLOTARG, MITOXANTRONE. Patient was hospitalized. Patient recovered.

Bevacizumab Side Effects Report #5513140-0
Physician from UNITED STATES reported BEVACIZUMAB problem on Nov 05, 2007. Male patient was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: apnoeic attack, caecitis, cardio-respiratory arrest, electroencephalogram abnormal, unresponsive to stimuli, . BEVACIZUMAB dosage: 5 MG/KG, Q2W. Patient was hospitalized and became disabled. Patient died on 10/20/2007.

Cap Side Effects Report #5517732-4
CAP VORINOSTAT UNK problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient, 18 years of age, weighting 114.0 lb, was diagnosed with acute myeloid leukaemia and was treated with CAP VORINOSTAT UNK. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, caecitis, cellulitis, febrile neutropenia, herpes simplex, malignant neoplasm progression, mouth injury, oral intake reduced, weight decreased, . CAP VORINOSTAT UNK dosage: 400 MG/DAILY/PO; 400 MG/DAILY/PO. During the same period patient was treated with CAP VORINOSTAT UNK, INJ DECITABINE UNK, INJ DECITABINE UNK. Patient was hospitalized. Patient died on 10/25/2007.

Cytoxan Side Effects Report #5527497-8
Consumer or non-health professional from UNITED STATES reported CYTOXAN problem on Nov 16, 2007. Female patient, 73 years of age, weighting 138.9 lb, was diagnosed with breast cancer and was treated with CYTOXAN. After drug was administered, patient experienced the following problems/side effects: abdominal pain, caecitis, colitis, hypertension, hypotension, neutropenia, sepsis, thrombocytopenia, . CYTOXAN dosage: unknown. During the same period patient was treated with ADRIAMYCIN, TAXOTERE, NEULASTA. Patient was hospitalized. Patient died on 01/17/2007.